Early mobilization of patients in the intensive care unit (ICU) is safe, feasible, and beneficial. However, implementation of early mobility as part of routine clinical care can be challenging. The...
Background: The standard of care (SOC) treatment (Tx) in the curative setting for patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) after 1st-line (1L) chemoimmunotherapy (CIT) is high-dose therapy with autologous stem cell rescue (HDT-ASCT) if responsive to 2L CIT; however, as many pts do not respond to or cannot tolerate 2L CIT, or are not intended for HDT-ASCT, outcomes remain poor.
Rio de Janeiro hosts the XIII World Congress of Intensive and Critical Care Medicine and the XXII Brazilian Congress of Intensive Care Medicine simultaneously.
The purpose of this study is to evaluate the benefit of panitumumab in addition to best supportive care compared to...
This guideline covers the clinical care of adults (18 years and over) who are dying during the last 2 to 3 days of life.
To identify the barriers and enablers that influence clinicians implementation of early rehabilitation in critical care...
We propose an integrated and adaptable approach to improve patient care and clinical outcomes through analgesia and light sedation, initiated early during an episode of critical illness and as a priority of care.
This study will be carried out as a retrospective, non-interventional observational review of medical records for patients in multiple countries...
To identify, evaluate and synthesise studies examining the barriers and enablers for survivors of critical illness to participate in physical activity in the ICU and post-ICU settings from the perspective...
Clinical study results show that RiaSTAP (fibrinogen concentrate [human]), from CSL Behring, can significantly reduce the need for blood transfusion...